Key Takeaways
- • Credit Suisse (Lux) Liquid Alternative Beta (LAB) received The Hedge Fund Journal's 2023 UCITS Hedge Award for best risk-adjusted returns, validating its performance relative to peer liquid alternative strategies.
- • The fund seeks to provide liquid, transparent, and broadly diversified exposure to hedge fund risk and return characteristics, benchmarked against the Credit Suisse/Tremont hedge fund indices, an industry-leading alternative beta tracking mechanism.
- • The Credit Suisse Liquid Alternative Beta Index (CSLAB) reflects overall hedge fund industry performance, with documented volatility including a 2.23% decline in one measured period and a 1.22% gain in March, demonstrating sensitivity to market conditions.
- • The fund is structured as a Luxembourg-registered UCITS vehicle (LEI: 549300JB67EAL9XN3I03), domiciled at 5, Rue Jean Monnet, Luxembourg, enabling access to European institutional and retail investors within a regulated framework.
- • The strategy employs long/short positioning across multiple asset classes to replicate hedge fund beta exposure while maintaining daily liquidity and transparency characteristics unavailable in traditional hedge fund vehicles.
Summary
Credit Suisse (Lux) Liquid Alternative Beta is a UCITS-regulated fund designed to deliver systematic exposure to hedge fund performance characteristics through a liquid, transparent vehicle. The fund received recognition from The Hedge Fund Journal in 2023 for superior risk-adjusted returns, a significant validation within the alternative asset management community. The award underscores the fund's competitive positioning relative to other liquid alternative strategies competing for institutional capital.
The fund's objective centers on replicating the risk-return profile of the broader hedge fund industry by tracking the Credit Suisse/Tremont hedge fund indices, which serve as the industry's primary benchmark for alternative beta. This approach allows investors to access diversified hedge fund exposure without direct fund-of-funds vehicles or the liquidity constraints typical of traditional hedge fund structures. The strategy encompasses long and short positions across major asset classes, providing the flexibility to capture hedge fund alpha sources through systematic methodology.
Performance tracking of the underlying Credit Suisse Liquid Alternative Beta Index demonstrates market responsiveness. The index recorded a 2.23% decline during one measurement period and a 1.22% gain in March, reflecting the cyclical nature of alternative strategies and market condition sensitivity. As a Luxembourg-domiciled UCITS product registered under LEI 549300JB67EAL9XN3I03, the fund operates within European regulatory parameters, enabling broad institutional distribution while maintaining daily liquidity and transparency standards required by institutional investors and family offices.
The fund structure addresses a persistent market need: institutional investors seeking hedge fund exposure with operational simplicity, daily pricing, and regulatory clarity. By removing the complexity of fund-of-funds structures while preserving diversified alternative beta access, Credit Suisse positions LAB as a gateway product for allocators transitioning capital from traditional alternatives to liquid alternative vehicles.
The fund's objective centers on replicating the risk-return profile of the broader hedge fund industry by tracking the Credit Suisse/Tremont hedge fund indices, which serve as the industry's primary benchmark for alternative beta. This approach allows investors to access diversified hedge fund exposure without direct fund-of-funds vehicles or the liquidity constraints typical of traditional hedge fund structures. The strategy encompasses long and short positions across major asset classes, providing the flexibility to capture hedge fund alpha sources through systematic methodology.
Performance tracking of the underlying Credit Suisse Liquid Alternative Beta Index demonstrates market responsiveness. The index recorded a 2.23% decline during one measurement period and a 1.22% gain in March, reflecting the cyclical nature of alternative strategies and market condition sensitivity. As a Luxembourg-domiciled UCITS product registered under LEI 549300JB67EAL9XN3I03, the fund operates within European regulatory parameters, enabling broad institutional distribution while maintaining daily liquidity and transparency standards required by institutional investors and family offices.
The fund structure addresses a persistent market need: institutional investors seeking hedge fund exposure with operational simplicity, daily pricing, and regulatory clarity. By removing the complexity of fund-of-funds structures while preserving diversified alternative beta access, Credit Suisse positions LAB as a gateway product for allocators transitioning capital from traditional alternatives to liquid alternative vehicles.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.